Marketing-authorisation holder · United States
Almatica
7 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
7 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ESCITALOPRAM15mg base · Capsule | Escitalopram | United States | Marketed | 2025 |
| GRALISE300mg | 450mg | 600mg | 750mg | 900mg · Tablet | Gabapentin | United States | Marketed | 2011 |
| LOREEV XR1.5mg | 1mg | 2mg | 3mg · Capsule, extended release | Lorazepam | United States | Marketed | 2021 |
| MACROBID75mg; 25mg · Capsule | Nitrofurantoin, Macrocrystalline | United States | Marketed | 1991 |
| MACRODANTIN100mg | 25mg | 50mg · Capsule | Nitrofurantoin, Macrocrystalline | United States | Marketed | 1970 |
| VENLAFAXINE BESYLATE112.5mg base · Tablet, extended release | Venlafaxine | United States | Marketed | 2022 |
| ZESTORETIC12.5mg; 10mg | 12.5mg; 20mg | 25mg; 20mg · Tablet | Hydrochlorothiazide, Lisinopril | United States | Marketed | 1989 |
Countries
Where it holds or makes medicines, with how many are current.